SERPINE1 and gastric cancer: At present, our study still has some limitations, such as a small clinical sample size, certain errors in the process of data collection, the direct mechanism of action of SERPINE1 in GC may not be detailed enough, and the molecular mechanism needs to be further verified by experiments and discussed in the follow-up study improvement.